151 related articles for article (PubMed ID: 31569615)
61. Indolyl-chalcone derivatives trigger apoptosis in cisplatin-resistant mesothelioma cells through aberrant tubulin polymerization and deregulation of microtubule-associated proteins.
Steinlein S; Essmann F; Ghilardi AF; Horn H; Schüler J; Hausser A; Sun L; Ott G; Kalla C
Front Oncol; 2023; 13():1190988. PubMed ID: 37305581
[TBL] [Abstract][Full Text] [Related]
62. Live-Cell Mesothelioma Biobank to Explore Mechanisms of Tumor Progression.
Oehl K; Kresoja-Rakic J; Opitz I; Vrugt B; Weder W; Stahel R; Wild P; Felley-Bosco E
Front Oncol; 2018; 8():40. PubMed ID: 29527515
[TBL] [Abstract][Full Text] [Related]
63. Induction of metallothionein expression by supplementation of zinc induces resistance against platinum-based treatment in malignant pleural mesothelioma.
Wyrich M; Ohlig H; Wessolly M; Mairinger E; Steinborn J; Brcic L; Hegedus B; Hager T; Greimelmaier K; Wohlschlaeger J; Mairinger FD; Borchert S
Transl Cancer Res; 2023 Aug; 12(8):1929-1936. PubMed ID: 37701096
[TBL] [Abstract][Full Text] [Related]
64. CDK4/6 Inhibition Enhances the Efficacy of Standard Chemotherapy Treatment in Malignant Pleural Mesothelioma Cells.
Terenziani R; Galetti M; La Monica S; Fumarola C; Zoppi S; Alfieri R; Digiacomo G; Cavazzoni A; Cavallo D; Corradi M; Tiseo M; Petronini PG; Bonelli M
Cancers (Basel); 2022 Nov; 14(23):. PubMed ID: 36497412
[TBL] [Abstract][Full Text] [Related]
65. A case of advanced malignant pleural mesothelioma treatment with chemotherapy and photodynamic therapy.
Ryu JW; Kim YS
Tuberc Respir Dis (Seoul); 2015 Jan; 78(1):36-40. PubMed ID: 25653696
[TBL] [Abstract][Full Text] [Related]
66. Screening of Pleural Mesothelioma Cell Lines for Kinase Activity May Identify New Mechanisms of Therapy Resistance in Patients Receiving Platin-Based Chemotherapy.
Borchert S; Suckrau PM; Wessolly M; Mairinger E; Hegedus B; Hager T; Herold T; Eberhardt WEE; Wohlschlaeger J; Aigner C; Bankfalvi A; Schmid KW; Walter RFH; Mairinger FD
J Oncol; 2019; 2019():2902985. PubMed ID: 31929796
[TBL] [Abstract][Full Text] [Related]
67. Current status and progress in immunotherapy for malignant pleural mesothelioma.
Sun B; Dong Y; Xu J; Wang Z
Chronic Dis Transl Med; 2022 Jun; 8(2):91-99. PubMed ID: 35774429
[TBL] [Abstract][Full Text] [Related]
68. Malignant pleural mesothelioma nodules remodel their surroundings to vascularize and grow.
Kovacs I; Bugyik E; Dezso K; Tarnoki-Zach J; Mehes E; Gulyas M; Czirok A; Lang E; Grusch M; Schelch K; Hegedus B; Horvath I; Barany N; Megyesfalvi Z; Tisza A; Lohinai Z; Hoda MA; Hoetzenecker K; Pezzella F; Paku S; Laszlo V; Dome B
Transl Lung Cancer Res; 2022 Jun; 11(6):991-1008. PubMed ID: 35832452
[TBL] [Abstract][Full Text] [Related]
69. Headspace analysis of mesothelioma cell lines differentiates biphasic and epithelioid sub-types.
Little LD; Carolan VA; Allen KE; Cole LM; Haywood-Small SL
J Breath Res; 2020 Sep; 14(4):046011. PubMed ID: 32731209
[TBL] [Abstract][Full Text] [Related]
70. Upregulation of Thymidylate Synthase Induces Pemetrexed Resistance in Malignant Pleural Mesothelioma.
Sato Y; Tomita M; Soga T; Ochiai A; Makinoshima H
Front Pharmacol; 2021; 12():718675. PubMed ID: 34646134
[TBL] [Abstract][Full Text] [Related]
71. Spotlight on bevacizumab and its potential in the treatment of malignant pleural mesothelioma: the evidence to date.
Levin PA; Dowell JE
Onco Targets Ther; 2017; 10():2057-2066. PubMed ID: 28435296
[TBL] [Abstract][Full Text] [Related]
72. Thonzonium bromide inhibits progression of malignant pleural mesothelioma through regulation of ERK1/2 and p38 pathways and mitochondrial uncoupling.
Dell'Anno I; Morani F; Patergnani S; Daga A; Pinton P; Giorgi C; Mutti L; Gemignani F; Landi S
Cancer Cell Int; 2024 Jun; 24(1):226. PubMed ID: 38951927
[TBL] [Abstract][Full Text] [Related]
73. Crosstalk with lung fibroblasts shapes the growth and therapeutic response of mesothelioma cells.
Chrisochoidou Y; Roy R; Farahmand P; Gonzalez G; Doig J; Krasny L; Rimmer EF; Willis AE; MacFarlane M; Huang PH; Carragher NO; Munro AF; Murphy DJ; Veselkov K; Seckl MJ; Moffatt MF; Cookson WOC; Pardo OE
Cell Death Dis; 2023 Nov; 14(11):725. PubMed ID: 37938546
[TBL] [Abstract][Full Text] [Related]
74. Medical treatment of malignant pleural mesothelioma relapses.
Petrini I; Lucchesi M; Puppo G; Chella A
J Thorac Dis; 2018 Jan; 10(Suppl 2):S333-S341. PubMed ID: 29507803
[TBL] [Abstract][Full Text] [Related]
75. ADAM17 Inhibition Increases the Impact of Cisplatin Treatment in Ovarian Cancer Spheroids.
Hedemann N; Herz A; Schiepanski JH; Dittrich J; Sebens S; Dempfle A; Feuerborn J; Rogmans C; Tribian N; Flörkemeier I; Weimer J; Krüger S; Maass N; Bauerschlag DO
Cancers (Basel); 2021 Apr; 13(9):. PubMed ID: 33922533
[TBL] [Abstract][Full Text] [Related]
76. Physicochemical and pharmacokinetic properties of polymeric films loaded with cisplatin for the treatment of malignant pleural mesothelioma.
Sonvico F; Barbieri S; Colombo P; Mucchino C; Barocelli E; Cantoni AM; Cavazzoni A; Petronini PG; Rusca M; Carbognani P; Ampollini L
J Thorac Dis; 2018 Jan; 10(Suppl 2):S194-S206. PubMed ID: 29507787
[TBL] [Abstract][Full Text] [Related]
77.
Anayama T; Taguchi M; Tatenuma T; Okada H; Miyazaki R; Hirohashi K; Kume M; Matsusaki K; Orihashi K
World J Clin Cases; 2019 Dec; 7(23):4036-4043. PubMed ID: 31832406
[TBL] [Abstract][Full Text] [Related]
78. Effect of naringenin and its combination with cisplatin in cell death, proliferation and invasion of cervical cancer spheroids.
Martínez-Rodríguez OP; González-Torres A; Álvarez-Salas LM; Hernández-Sánchez H; García-Pérez BE; Thompson-Bonilla MDR; Jaramillo-Flores ME
RSC Adv; 2020 Dec; 11(1):129-141. PubMed ID: 35423031
[TBL] [Abstract][Full Text] [Related]
79. Establishment and characterization of NCC-DMM1-C1, a novel patient-derived cell line of desmoplastic malignant pleural mesothelioma.
Noguchi R; Yoshimatsu Y; Ono T; Sei A; Motoi N; Yatabe Y; Yoshida Y; Watanabe S; Kondo T
Oncol Lett; 2022 Feb; 23(2):64. PubMed ID: 35069873
[TBL] [Abstract][Full Text] [Related]
80.
Doi T; Ogawa H; Tanaka Y; Hayashi Y; Maniwa Y
Oncol Lett; 2020 Dec; 20(6):362. PubMed ID: 33133262
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
